Advertisement

The effect of doxorubicin incorporated into a phospholipid delivery nanosystem on HepG2 cells proteome

  • K. G. Kuznetzova
  • E. V. Kazlas
  • T. I. Torkhovskaya
  • P. A. Karalkin
  • I. V. Vachrushev
  • T. S. Zakharova
  • M. A. Sanzhakov
  • S. A. Moshkovskii
  • O. M. Ipatova
Article

Abstract

A phospholipid drug delivery nanosystem with particle size up to 30 nm elaborated at the Orekhovich Institute of Biomedical Chemistry (Russian Academy of Medical Sciences) has been used earlier for incorporation of doxorubicin (Doxolip). This system demonstrated higher antitumor effect in vivo as compared with free doxorubicin. In this study the effect of this nanosystem containing doxorubicin on HepG2 cell proteome has been investigated. Cells were incubated in a medium containing phospholipid nanoparticles (0.5 μg/mL doxorubicin, 10 μg/mL phosphatidylcholine). After incubation for 48 h their survival represented 10% as compared with untreated cells. Cell proteins were analyzed by quantitative two-dimensional gel electrophoresis followed by identification of differentially expressed proteins with MALDI-TOF mass spectrometry. The phospholipid transport nanosystem itself insignificantly influenced the cell proteome thus confirming previous data on its safety. Doxorubicin, as both free substance and Doxolip (i.e., included into phospholipid nanoparticles) induced changes in expression of 28 proteins. Among these proteins only four of them demonstrated different in response to the effect of the free drug substance and Doxolip. Doxolip exhibited a more pronounced effect on expression of certain proteins; the latter indirectly implies increased penetration of the drug substance (included into nanoparticles) into the tumor cells. Increased antitumor activity of doxorubicin included into phospholipid nanoparticles may be associated with more active increase of specific protein expression.

Keywords

phospholipid nanoparticles proteome doxorubicin HepG2 cells MALDI-TOF mass spectrometry 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Dusinska, M., Nanomedicine, 2009, vol. 4, pp. 605–607.CrossRefGoogle Scholar
  2. 2.
    Archakov, A.I., Biomed. Khim., 2010, vol. 56, pp. 7–25.Google Scholar
  3. 3.
    Govorun, V.M. and Archakov, A.I., Biochemistry (Moscow), 2002, vol. 67, pp. 1341–1359.CrossRefGoogle Scholar
  4. 4.
    Hong, M.L., Jiang, N., Gopinath, S., and Chew, F.T., Clin. Exp. Pharmacol. Physiol., 2006, vol. 33, pp. 563–568.CrossRefGoogle Scholar
  5. 5.
    Moshkovskii, S.A., Sokolova, E.E., Brattseva, E.V., Karpova, M.A., Pyatnitskiy, M.A., Kubanova, A.A., and Archakov, A.I., Proteomics Clin. Appl., 2011, vol. 5, no. 78, pp. 432–439.CrossRefGoogle Scholar
  6. 6.
    Agrawal, G.K., Timperio, A.M., Zolla, L., Bansal, V., Shukla, R., and Rakwal, R., J. Proteomics, 2013, Apr. 22. pii: S1874–3919 [Epub ahead of print].Google Scholar
  7. 7.
    Johnson, C.J., Zhukovsky, N., Cass, A.E., and Nagy, J.M., Proteomics, 2008, vol. 8, no. 4, pp. 715–730.CrossRefGoogle Scholar
  8. 8.
    Rafati, H. and Mirzajani, F., Pharmazie, 2011, vol. 66, no. 1, pp. 31–36.Google Scholar
  9. 9.
    Archakov, A.I., Guseva, M.K., Uchaikin, V.F., Ipatova, O.M., Tikhonova, E.G., Medvedeva, N.V., Lisitsa, A.V., Prozoroskii, V.N., Strekalova, O.S., and Shironin, A.V., Rus Patent no. 2391966, Byul. Izobret., 2010, no. 17.Google Scholar
  10. 10.
    Ipatova, O.M., Prozorovskiy, V.N., Medvedeva, N.V., Shironin, A.V., Strekalova, O.S., Ivanova, N.D., Torkhovskaya, T.I., and Archakov, A.I., Eur. Congress for Drug Discovery (MipTec), 2010, Basel, Abstr. 80.Google Scholar
  11. 11.
    Archkov, A.I., Ipatova, O.M., Medvedeva, N.V., Prozoroskii, V.N., Torkhovskaya, T.I., Tikhonova, E.G., Zykova, M.G., and Voskresenskaya, A.A., Rus. Patent no. 2411935, Byul. Izobret., 2011, no. 5.Google Scholar
  12. 12.
    Zykova, M.A., Ipatova, O.M., Prozorovskii, V.N., Medvedeva, N.V., Voskresenskaya, A.A., Zakharova, T.S., and Torkhovskaya, T.I., Biomed. Khim., 2011, vol. 57, pp. 174–179.Google Scholar
  13. 13.
    Zykova, M.A., Medvedeva, N.V., Torkhovskaya, T.I., Tikhonova, E.G., Prozorovskii, V.N., Zakharova, T.S., and Ipatova, O.M., Exp. Oncol., 2012, vol. 34, no. 4, pp. 323–326.Google Scholar
  14. 14.
    Hammer, E., Bien, S., Salazar, M.G., Steil, L., Scharf, C., Hildebrandt, P., Schroeder, H.W., Kroemer, H.K., Vösker, U., and Ritter, C.A., Proteomics, 2010, vol. 10, pp. 99–114.CrossRefGoogle Scholar
  15. 15.
  16. 16.
    Gorg, A., Postel, W., and Gunther, S., Electrophoresis, 1985, vol. 6, pp. 599–604.CrossRefGoogle Scholar
  17. 17.
    O’Farrell, P., J. Biol. Chem., 1975, vol. 250, pp. 4007–4021.Google Scholar
  18. 18.
    Mortz, E., Krogh, T.N., Vorum, H., and Görg, A., Proteomics, 2001, vol. 1, pp. 1359–1363.CrossRefGoogle Scholar
  19. 19.
    Van Summeren, A., Renes, J., Bouwman, F.G., Noben, J.P., van Delft, J.H., Kleinjans, J.C., and Mariman, E.C., Toxicol. Sci., 2011, vol. 129, no. 1, pp. 109–122.CrossRefGoogle Scholar
  20. 20.
    Havlis, J., Thomas, H., Sebela, M., and Shevchenko, A., Anal. Chem., 2003, vol. 75, no. 6, pp. 1300–1306.CrossRefGoogle Scholar
  21. 21.
    Bien, S., Ritter, C.A., Kranz, M., Scharf, C., Steil, L., Hummel, M., Vösker, U., Cascorbi, I., and Kroemer, H.K., J. Clin. Pharmacol. Ther., 2004, vol. 42, no. 11, pp. 640–641.CrossRefGoogle Scholar
  22. 22.
    Wu, Z., Jia, X., de la Cruz, L., Su, X.C., Marzolf, B., Troisch, P., Zak, D., Hamilton, A., Whittle, B., Yu, D., Sheahan, D., Bertram, E., Aderem, A., Otting, G., Goodnow, C.C., and Hoyne, G.F., Immunity, 2008, vol. 29, pp. 863–875.CrossRefGoogle Scholar
  23. 23.
    Robertson, N., Potter, C., and Harris, A.L., Cancer Research, 2004, vol. 64, pp. 6160–6165.CrossRefGoogle Scholar
  24. 24.
    Li, X., Ding, L., Xu, Y., Wang, Y., and Ping, Q., Int. J. Pharm., 2009, vol. 373, pp. 116–123.CrossRefGoogle Scholar
  25. 25.
    Li, L., Gong, H., Yu, H., Liu, X., Liu, Q., Yan, G., Zhang, Y., Lu, H., Zou, Y., and Yang, P., J. Cell Biochem., 2012, vol. 113, pp. 3788–3796.CrossRefGoogle Scholar
  26. 26.
    Honoré, B., Buus, S., and Claësson, M.H., Proteome Sci., 2008, vol. 6, p. 18.CrossRefGoogle Scholar

Copyright information

© Pleiades Publishing, Ltd. 2014

Authors and Affiliations

  • K. G. Kuznetzova
    • 1
  • E. V. Kazlas
    • 1
  • T. I. Torkhovskaya
    • 1
  • P. A. Karalkin
    • 1
  • I. V. Vachrushev
    • 1
  • T. S. Zakharova
    • 1
  • M. A. Sanzhakov
    • 1
  • S. A. Moshkovskii
    • 1
  • O. M. Ipatova
    • 1
  1. 1.Orekhovich Institute of Biomedical Chemistry of Russian Academy of Medical SciencesMoscowRussia

Personalised recommendations